NewAmsterdam Pharma Company NV (NAMS) Is A Good Investment At Current Valuations
NewAmsterdam Pharma Company NV (NASDAQ:NAMS) concluded the trading at $24.95 on Friday, January 10 with a fall of -2.35% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $25.55 and 5Y monthly